Major depressive disorder (MDD) is characterized by mood, vegetative, cognitive, and even
psychotic symptoms and signs that can cause substantial impairments in quality of life and …

Millions of people around the world suffer from psychiatric illnesses, causing unbearable
burden and immense distress to patients and their families. Accumulating evidence …

Recovery from major depressive disorder is difficult, particularly in patients who are
refractory to antidepressant treatments. To examine factors that regulate recovery, we …

Major depressive disorder is a highly prevalent, chronic and recurring disorder, associated
with substantial impairment in cognitive and interpersonal functions. Accumulating evidence …

Major depressive disorder (MDD) or Depression is one of the serious neuropsychiatric
disorders affecting over 280 million people worldwide. It is 4th important cause of disability …

Major depressive disorder (MDD) is a common condition that afflicts the general population
across a broad spectrum of ages and social backgrounds. MDD has been identified by the …

Lipopolysaccharide (LPS) might affect the central nervous system by causing
neuroinflammation, which subsequently leads to brain damage and dysfunction. In this …

Major depressive disorder (MDD) is associated with cognitive dysfunction encompassing
several domains, including memory, executive function, processing speed and attention …

Neonatal infection is associated with increased lifetime risk for neuropsychiatric disorders
including anxiety and depression, with evidence showing that dysregulation of the …

Previous findings have shown that patients with depression express higher levels of
proinflammatory cytokines such as TNF-α and IL-6. We have recently found that Infliximab (a …